Maryam Lustberg, MD
Medical Oncology · Columbus, OHNPI 1639111065
Payments from drug & device makers
Across 234 payments — averaging $8981.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$960K
- Seagen Inc.$284K
- Pfizer$218K
- Merck$169K
- Daiichi Sankyo Inc.$155K
- Astellas Pharma Global Development$111K
- plus $205K from 13 others
Across 11 payments — averaging $13,334 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$133K
- American Regent$11K
- Novartis$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 18 | $960,059 |
| Seagen Inc. | 25 | $283,797 |
| Pfizer | 25 | $217,600 |
| Merck | 2 | $168,517 |
| Daiichi Sankyo Inc. | 35 | $154,897 |
| Astellas Pharma Global Development | 3 | $111,384 |
| AstraZeneca | 45 | $104,258 |
| Lilly USA, LLC | 28 | $23,041 |
| Novartis | 7 | $20,889 |
| Gilead | 12 | $14,342 |
| Bayer | 15 | $12,745 |
| Novartis Pharma AG | 4 | $7,756 |
| Stemline Therapeutics Inc. | 2 | $6,630 |
| Astrazeneca UK Limited | 2 | $6,565 |
| Genentech USA, Inc. | 3 | $3,042 |
| Sandoz | 2 | $2,880 |
| Caris MPI, Inc. | 3 | $1,800 |
| Sanofi | 2 | $1,475 |
| Foundation Medicine, Inc. | 1 | $62 |
How this compares
$2,101,739 in reported general payments places this provider in the 85th percentile of 157 medical oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Columbus
- Kai HeColumbus$10.9M
- Timothy BurnsColumbus$7.2M
- Dwight OwenColumbus$6.8M
- David CarboneColumbus$5.4M
- Manisha ShahColumbus$4.3M
- Gregory OttersonColumbus$4.1M
- Marcelo BonomiColumbus$4M
- Christian RolfoColumbus$3.8M
- Wendy RathmellColumbus$2.8M
- John HaysColumbus$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.